GAMBACORTI PASSERINI CARLO

Posizione organizzativa: 
Ruolo: 
Professore ordinario
Settore scientifico disciplinare: 
MALATTIE DEL SANGUE (MED/15)
Telefono: 
0264488362
0264488057
Stanza: 
U08, Piano: P04, Stanza: 4041
Via Cadore, 48 - 20900 MONZA
U8, Piano: IV, Stanza: 4-12
Via Cadore, 48 - 20900 MONZA

Didattica

Pubblicazioni

  • Giardini, V., Carrer, A., Casati, M., Contro, E., Vergani, P., & Gambacorti Passerini, C. (2020). Increased sFLT-1/PlGF ratio in COVID-19: A novel link to angiotensin II-mediated endothelial dysfunction. AMERICAN JOURNAL OF HEMATOLOGY, 95(8), E188-E191. Dettaglio
  • Ramazzotti, D., Angaroni, F., Maspero, D., Gambacorti-Passerini, C., Antoniotti, M., Graudenzi, A., et al. (2020). Characterization of intra-host SARS-CoV-2 variants improves phylogenomic reconstruction and may reveal functionally convergent mutations [Rapporto tecnico]. Dettaglio
  • Brummendorf, T., Gambacorti Passerini, C., Bushmakin, A., Cappelleri, J., Viqueira, A., Reisman, A., et al. (2020). Relationship between molecular response and quality of life with bosutinib or imatinib for chronic myeloid leukemia. ANNALS OF HEMATOLOGY, 99(6), 1241-1249. Dettaglio
  • Colombo, F., Pintarelli, G., Galvan, A., Noci, S., Corli, O., Skorpen, F., et al. (2020). Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients. SCIENTIFIC REPORTS, 10(1). Dettaglio
  • Hochhaus, A., Gambacorti Passerini, C., Abboud, C., Gjertsen, B., Brummendorf, T., Smith, B., et al. (2020). Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study. LEUKEMIA, 34(8), 2125-2137. Dettaglio